NORDIC | BIOTECH & HEALTHCARE Your insights to listed Danish & Nordic biotech & healthcare stocks.
The Nordic biotech and healthcare stocks continue on the positive upward trend since the bottom in October 2023. The Danish stocks fared better than the Nordic counterparts for yet another week. Year-to-date the Danish biotech stocks have already delivered a double-digit return.
In the past week, Genmab announced sales of Darzalex in 2023, Evaxion expanded its vaccine development, CS Medica expanded in Australia, Curasight received its first milestone from the Curium deal, and shareholders in SynAct Pharma wants a new board of directors. 12 of the 20 companies had a positive share price development the past week and 12 companies have had a positive share price performance year-to-date.
CS Medica is the best-performing Danish stock year-to-date with a 72% return and Oncozenge AB was the best investment last week.
Stay tuned to the developments of impact companies and stocks in the Nordics with the NORDIC | IMPACT newsletter that helps you to invest more sustainably in the businesses of tomorrow.
DANISH COMPANY NEWS